Comparison Between Two Dose Levels of Daunorubicin and Between One vs. Two Induction Cycles for Adult Patients With AML

NCT02140242 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

721

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Myelocytic, Acute

Interventions

DRUG: study part 1 - dose daunorubicin
PROCEDURE: induction cycles

Sponsor

Technische Universität Dresden

Collaborators

[object Object]
[object Object]